Solta Medical Appoints Lisa Parr as Vice President of Regulatory
Affairs and Clinical Affairs
HAYWARD, Calif., Nov. 15, 2012 /PRNewswire/ -- Solta Medical,
Inc. (NASDAQ: SLTM), a global leader in the medical aesthetics
market, today announced the appointment of Dr. Lisa Parr to the position of Vice President of
Regulatory Affairs and Clinical Affairs.
Dr. Parr brings nearly 25 years of senior management experience
successfully leading clinical and regulatory initiatives for
medical device, pharmaceutical, and consumer product companies. Dr.
Parr was most recently the Vice President of Clinical, Regulatory,
and Quality Affairs at Tria Beauty where she secured a number of
regulatory clearances for light-based aesthetic and therapeutic
devices for at-home use.
"I am delighted that Lisa is joining our management team. She
has established a reputation among her peers for collaborative team
building and disciplined execution," said Stephen J. Fanning, Chairman, President &
CEO. "Her extensive and diverse expertise in regulatory affairs and
clinical development will be a valuable asset in opening new
markets for Solta products and advancing our new product
pipeline."
About Solta Medical, Inc.
Solta Medical, Inc. is a
global leader in the medical aesthetics market providing
innovative, safe, and effective solutions for patients that enhance
and expand the practice of medical aesthetics for physicians. The
company offers six aesthetic energy devices to address a range of
issues, including skin resurfacing and rejuvenation with Fraxel®
and Clear + Brilliant(TM), body contouring and skin tightening with
Liposonix® and Thermage® and acne reduction with Isolaz® and
CLARO(TM). As the innovator and leader in fractional laser
technology, Fraxel delivers minimally invasive clinical solutions
to resurface aging and sun damaged skin. Using similar fractional
laser technology, Clear + Brilliant is a unique, cost-effective
treatment to prevent and improve the early signs of photoaging. For
body contouring, Liposonix is a non-surgical treatment to reduce
waist circumference with advanced high-intensity focused ultrasound
(HIFU) technology to permanently destroy targeted fat beneath the
skin. Thermage is an innovative, non-invasive radiofrequency
procedure for tightening and contouring skin. Isolaz was the first
laser or light based system indicated for the treatment of
inflammatory acne, comedonal acne, pustular acne, and
mild-to-moderate inflammatory acne. CLARO is a personal care acne
system that is the first FDA cleared over-the-counter IPL device
that uses a powerful combination of both heat and light to clear
skin quickly and naturally. More than two million procedures have
been performed with Solta Medical's portfolio of products around
the world. For more information about Solta Medical, call
1-877-782-2286 or log on to www.Solta.com.
Web Site: http://www.Solta.com
SOURCE Solta Medical, Inc.